Особенности лабораторной диагностики уровня антимюллерова гормона

1. Bruno-Gaston J., Jung J., Kumar T., Zarutskie P., Gibbons W., Devaraj S. Association of ovarian response with picoAMH in women undergoing controlled ovarian hyperstimulation. Clin. Biochem. 2021; 95: 34-40. https://dx.doi.org/10.1016/j.clinbiochem.2021.05.007
2. Josso N., Rey R.A. What does AMH tell us in pediatric disorders of sex development? Front. Endocrinol. (Lausanne). 2020; 11: 619. https://dx.doi.org/10.3389/fendo.2020.00619
3. Dietz de Loos A., Hund M., Buck K., Meun C., Sillman J., Laven J.S.E. Antimüllerian hormone to determine polycystic ovarian morphology. Fertil. Steril. 2021; 116(4): 1149-57. https://dx.doi.org/10.1016/j.fertnstert.2021.05.094
4. Nelson S.M., Davis S.R., Kalantaridou S., Lumsden M.A., Panay N., Anderson R.A. Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review. Hum. Reprod. Update. 2023; 29(3): 327-46. https://dx.doi.org/10.1093/humupd/dmac045
5. Geerts I., Vergote I., Neven P., Billen J. The role of inhibins B and antimüllerian hormone for diagnosis and follow-up of granulosa cell tumors. Int. J. Gynecol. Cancer. 2009; 19(5): 847-55. https://dx.doi.org/10.1111/IGC.0b013e3181a702d1
6. Всемирная организация здравоохранения. ВОЗ: Бесплодием страдает каждый шестой человек в мире. 4 апреля 2023.
7. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Женское бесплодие. М.; 2024. 63 с.
8. Gleicher N., Weghofer A., Barad D.H. Defining ovarian reserve to better understand ovarian aging. Reprod. Biol. Endocrinol. 2011; 9: 23. https://dx.doi.org/10.1186/1477-7827-9-23
9. Moolhuijsen L.M.E., Visser J.A. Anti-müllerian hormone and ovarian reserve: update on assessing ovarian function. J. Clin. Endocrinol. Metab. 2020; 105(11): 3361-73. https://dx.doi.org/10.1210/clinem/dgaa513
10. Di Clemente N., Racine C., Pierre A., Taieb J. Anti-müllerian hormone in female reproduction. Endocr. Rev. 2021; 42(6): 753-82. https://dx.doi.org/10.1210/endrev/bnab012
11. Rudnicka E., Kunicki M., Calik-Ksepka A., Suchta K., Duszewska A., Smolarczyk K. et al. Anti-müllerian hormone in pathogenesis, diagnostic and treatment of PCOS. Int. J. Mol. Sci. 2021; 22(22): 12507. https://dx.doi.org/10.3390/ijms222212507
12. Lie Fong S., Visser J.A., Welt C.K., de Rijke Y.B., Eijkemans M.J., Broekmans F.J. et al. Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J. Clin. Endocrinol. Metab. 2012; 97(12): 4650-5. https://dx.doi.org/10.1210/jc.2012-1440
13. Meczekalski B., Czyzyk A., Kunicki M., Podfigurna-Stopa A., Plociennik L., Jakiel G. et al. Fertility in women of late reproductive age: the role of serum anti-müllerian hormone (AMH) levels in its assessment. J. Endocrinol. Invest. 2016; 39(11): 1259-65. https://dx.doi.org/10.1007/s40618-016-0497-6
14. Nelson S.M., Aijun S., Ling Q., Tengda X., Wei X., Yan D. et al. Ethnic discordance in serum anti-müllerian hormone in healthy women: a population study from China and Europe. Reprod. Biomed. Online. 2020; 40(3): 461-7. https://dx.doi.org/10.1016/j.rbmo.2019.11.013
15. Bleil M.E., Gregorich S.E., Adler N.E., Sternfeld B., Rosen M.P., Cedars M.I. Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women. Fertil. Steril. 2014; 101(1): 199-207. https://dx.doi.org/10.1016/j.fertnstert.2013.09.015
16. Iglesias C., Banker M., Mahajan N., Herrero L., Meseguer M., Garcia-Velasco J.A. Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women. Fertil. Steril. 2014; 102(1): 244-9. https://dx.doi.org/10.1016/j.fertnstert.2014.03.050
17. Ji M., Kim K.R., Kim H.K., Lee W., Yun Y.M., Chun S. et al. Age group-specific reference intervals for the elecsys anti-müllerian hormone assay in healthy Korean women: a nationwide population-based study. Ann. Lab. Med. 2022; 42(6): 621-9. https://dx.doi.org/10.3343/alm.2022.42.6.621
18. Khodavirdilou R., Pournaghi M., Rezaei Y.R., Hajizadeh K., Khodavirdilou L., Javid F. et al. Does anti-müllerian hormone vary during a menstrual cycle? A systematic review and meta-analysis. J. Ovarian Res. 2022; 15(1): 78. https://dx.doi.org/10.1186/s13048-022-01006-z
19. Bungum L., Tagevi J., Jokubkiene L., Bungum M., Giwercman A., Macklon N. et al. The impact of the biological variability or assay performance on AMH measurements: a prospective cohort study with AMH tested on three analytical assay-platforms. Front. Endocrinol. (Lausanne). 2018; 9: 603. https://dx.doi.org/10.3389/fendo.2018.00603
20. Şükür Y.E., Aslan B., Kaplan N.B., Doğru M., Özmen B., Sönmezer M. et al. Inter-cycle variability of anti-müllerian hormone: implications for predicting controlled ovarian stimulation cycle outcomes. J. Ovarian Res. 2024; 17(1): 209. https://dx.doi.org/10.1186/s13048-024-01517-x
21. Moslehi N., Shab-Bidar S., Ramezani Tehrani F., Mirmiran P., Azizi F. Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis. Menopause. 2018; 25(9): 1046-55. https://dx.doi.org/10.1097/GME.0000000000001116
22. Dennis N.A., Houghton L.A., Pankhurst M.W., Harper M.J., McLennan I.S. Acute supplementation with high dose vitamin D3 increases serum anti-müllerian hormone in young women. Nutrients. 2017; 9(7): 719. https://dx.doi.org/10.3390/nu9070719
23. Li H.W.R., Robertson D.M., Burns C., Ledger W.L. Challenges in measuring AMH in the clinical setting. Front. Endocrinol. (Lausanne). 2021; 12: 691432. https://dx.doi.org/10.3389/fendo.2021.691432
24. Li H.W., Wong B.P., Ip W.K., Yeung W.S., Ho P.C., Ng E.H.Y. Comparative evaluation of three new commercial immunoassays for anti-müllerian hormone measurement. Hum. Reprod. 2016; 31(12): 2796-2802. https://dx.doi.org/10.1093/humrep/dew248
25. Moolhuijsen L.M.E., Louwers Y.V., Laven J.S.E., Visser J.A. Comparison of 3 different AMH assays with AMH levels and follicle count in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2022; 107(9): e3714-22. https://dx.doi.org/10.1210/clinem/dgac370
26. Plociennik L., Nelson S.M., Lukaszuk A., Kunicki M., Podfigurna A., Meczekalski B. et al. Age-related decline in AMH is assay dependent limiting clinical interpretation of repeat AMH measures across the reproductive lifespan. Gynecol. Endocrinol. 2018; 34(2): 115-9. https://dx.doi.org/10.1080/09513590.2017.1358708
27. Jeong H.G., Kim S.K., Lee J.R., Jee B.C. Correlation of oocyte number with serum anti-Müllerian hormone levels measured by either access or elecsys in fresh in vitro fertilization cycles. Clin. Exp. Reprod. Med. 2022; 49(3): 202-9. https://dx.doi.org/10.5653/cerm.2022.05211
28. Anderson R.A., Anckaert E., Bosch E., Dewailly D., Dunlop C.E., Fehr D. et al. Prospective study into the value of the automated elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool. Fertil. Steril. 2015; 103(4): 1074-80.e4. https://dx.doi.org/10.1016/j.fertnstert.2015.01.004
29. Iliodromiti S., Salje B., Dewailly D., Fairburn C., Fanchin R., Fleming R. et al. Non-equivalence of anti-müllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing. Hum. Reprod. 2017; 32(8): 1710-15. https://dx.doi.org/10.1093/humrep/dex219
30. Берестовская В.С., Эмануэль А.В., Скибо И.И., Эмануэль В.Л. Интерпретация референтных интервалов и порогов клинических решений. Медицинский алфавит. 2024; 20: 79-82.
31. Barbagallo F., van der Ham K., Willemsen S.P., Louwers Y.V., Laven J.S. Age-related curves of AMH using the gen II, the picoAMH, and the elecsys assays in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2024; 109(10): 2561-70. https://dx.doi.org/10.1210/clinem/dgae153
32. Ferguson J., Hockley J., Rigsby P., Burns C. Establishment of a WHO reference reagent for anti-mullerian hormone. Reprod. Biol. Endocrinol. 2020; 18(1): 86. https://dx.doi.org/10.1186/s12958-020-00641-9

Поступила 10.07.2025

Принята в печать 28.07.2025